Comerica Bank acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 30,710 shares of the medical equipment provider’s stock, valued at approximately $588,000. Comerica Bank owned approximately 0.08% of Lantheus Holdings as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Bank of New York Mellon Corp raised its position in shares of Lantheus Holdings by 6.3% in the first quarter. Bank of New York Mellon Corp now owns 68,473 shares of the medical equipment provider’s stock worth $856,000 after buying an additional 4,084 shares in the last quarter. First Trust Advisors LP raised its position in shares of Lantheus Holdings by 24.8% in the second quarter. First Trust Advisors LP now owns 23,468 shares of the medical equipment provider’s stock worth $414,000 after buying an additional 4,669 shares in the last quarter. Parametric Portfolio Associates LLC raised its position in shares of Lantheus Holdings by 28.9% in the first quarter. Parametric Portfolio Associates LLC now owns 22,530 shares of the medical equipment provider’s stock worth $282,000 after buying an additional 5,058 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Lantheus Holdings in the second quarter worth $102,000. Finally, Municipal Employees Retirement System of Michigan purchased a new stake in shares of Lantheus Holdings in the second quarter worth $107,000. Institutional investors own 84.35% of the company’s stock.

Lantheus Holdings, Inc. (NASDAQ:LNTH) opened at 17.35 on Friday. The stock’s 50 day moving average price is $17.23 and its 200-day moving average price is $17.23. The company has a market capitalization of $648.02 million, a PE ratio of 23.70 and a beta of 0.94. Lantheus Holdings, Inc. has a 52 week low of $7.61 and a 52 week high of $17.95.

Lantheus Holdings (NASDAQ:LNTH) last announced its earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.18. The firm had revenue of $88.83 million for the quarter, compared to analysts’ expectations of $80.56 million. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The business’s revenue was up 13.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.24 EPS. On average, equities research analysts predict that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current fiscal year.

In other news, major shareholder Avista Capital Partners Gp, Ll sold 87,939 shares of the company’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $17.40, for a total transaction of $1,530,138.60. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mary Anne Heino sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $18.05, for a total transaction of $180,500.00. Following the sale, the chief executive officer now owns 592,468 shares in the company, valued at $10,694,047.40. The disclosure for this sale can be found here. Insiders have sold a total of 906,344 shares of company stock worth $15,499,626 over the last 90 days. Corporate insiders own 2.30% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Comerica Bank Acquires New Stake in Lantheus Holdings, Inc. (LNTH)” was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2017/09/24/comerica-bank-acquires-new-stake-in-lantheus-holdings-inc-lnth.html.

A number of equities research analysts recently issued reports on LNTH shares. Credit Suisse Group increased their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “buy” rating and issued a $22.00 price objective (up previously from $18.00) on shares of Lantheus Holdings in a research report on Wednesday, August 2nd. Cantor Fitzgerald started coverage on Lantheus Holdings in a research report on Monday, July 17th. They issued an “overweight” rating and a $22.00 price objective on the stock. Zacks Investment Research downgraded Lantheus Holdings from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 5th. Finally, BidaskClub downgraded Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 17th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Lantheus Holdings currently has a consensus rating of “Buy” and a consensus target price of $18.60.

Lantheus Holdings Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Institutional Ownership by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.